COVID-19 maganin alurar rigakafi: Bukatar yanar gizo mai ba da cikakken bayani

Italiya COVID maganin alurar riga kafi: Abubuwan da ba a fifiko sun fi rinjaye
cikakken allurar rigakafi
Avatar na Behrouz Pirouz
Written by Berous Pirouz

Gabobin jikin mutum suna da alaƙa da juna, kuma tasirin da ba zato ba tsammani na magani zai iya faruwa. Hakan ya faru cewa ba zato ba tsammani an dakatar da magunguna na yau da kullun waɗanda aka siyar ba tare da buƙatar takardar likita ba.

  1. A ina mutum zai sami rajistar yiwuwar alamun bayyanar da ba zato ba tsammani bayan rigakafin COVID-19?
  2. Kusan mutane miliyan 500 zuwa yau sun karɓi alluran rigakafin COVID-19 daban-daban, a cikin su miliyan 135 kuma sun karɓi na biyu.
  3. Bincike kan al'amuran yau da kullun da mahimmanci suna da mahimmanci, musamman ga mafi munin lokuta, kamar yadda ya faru lokacin da mutuwa da thrombosis suka faru 'yan makonnin da suka gabata wanda ya haifar da dakatar da AstraZeneca.

Wannan haka lamarin yake, alal misali, na Ranitidine, sanannen magani mai ƙwanna zuciya wanda aka gano a cikin 1976 kuma a cikin kasuwanci tun 1981 wanda FDA ta buƙaci ficewa daga kasuwa shekara guda da ta gabata. A wasu halaye kuma, wasu magunguna har yanzu an yarda amma amfani da su na bukatar kulawa ta musamman, kamar yadda yake a batun “Tamsulosin,” wani magani ne na yau da kullum da ake yi wa prostate wanda zai iya shafar idanu, wanda ke bukatar kulawa ta musamman yayin da mara lafiyar da ke shan sa dole ne ya samu cataract ko glaucoma tiyata.

Ana amfani da waɗannan magungunan ta ƙananan ƙananan ɓangarorin jama'a. Duk da wannan, binciken yanar gizo don tasirin su zai sami sauƙin nassoshi da kuma magunguna masu amfani na iyakantaccen amfani.

Ga cututtukan cututtukan COVID-19, wannan ba haka bane. Wannan na iya zama abin mamaki, idan akayi la'akari da cewa wani adadi mai yawa na mutanen da ke amfani dasu yana amfani dasu, wanda a zahiri zai zama kusan dukkanin mutanen duniya. Bayanin da masu kera ke bayarwa, tabbas, akwai, amma wannan ya dogara ne da lamuran da suka faru yayin gwajin rigakafin. Girman samfurin gwajin ya kai dubun dubbai, tsari na girman da bai kai kusan mutane miliyan 500 ba, waɗanda har yanzu sun karɓi daban-daban rigakafin COVID-19, daga cikinsu miliyan 135 suka karba kuma kashi na biyu ba tare da bukatar cewa wadannan alkaluma na ci gaba da karuwa ba a kowace rana yayin da ake ci gaba da aikin riga-kafi.

Fadada samfurin yana ba da damar bayyanar sabbin abubuwa wadanda ba su faru ba a lokacin gwajin. Baya ga lamuran da suka fi dacewa, dole ne a gano kuma a bincika illolin ƙananan ƙididdiga. Koyaya, dubawa mai sauƙi a cikin injin bincike kamar Google wanda ke yin tambayoyi kamar, "A ina zan iya rubuta baƙon alamu bayan alurar rigakafin COVID-19?" ko "alamun alamun da ba a san su ba bayan rigakafin COVID-19" ya nuna cewa irin wannan rukunin yanar gizon ba ya wanzu inda mutum zai iya samun rajistar yiwuwar alamun bayyanar da ba zato ba tsammani bayan rigakafin COVID-19.

Mutum zai iya samun articlesan labarai kamar “Menene illar maganin alurar riga kafi na AstraZeneca?” "Mene ne illar allurar ta Pfizer?" Dubawa da sauri a kansu yana tabbatar da cewa banda shahararrun alamun cutar, akwai kuma wasu ƙalilan waɗanda ba su da yawa. Misali, mutane 4 cikin 600 sun yi sharhi bayan sun sami matsalolin mafitsara bayan allurar ta AstraZeneca, tasirin da ba a ambata a cikin jerin abubuwan da aka saba ganowa na matsalolin da aka gano lokacin gwajin. Wani abu mai kama da juna yana faruwa don rigakafin Pfizer-BioNTech. Daga cikin sama da maganganu 200 kan illolin, 2 daga cikinsu kuma suna bayar da rahoton matsalolin mafitsara, kuma 15 sun ba da rahoton ƙwanƙwasawar jiki wanda a wasu lokuta ya kai makonni 2.

Game da marubucin

Avatar na Behrouz Pirouz

Berous Pirouz

Share zuwa...